L17-Immunisation and Vaccine Development

Lecture & Workshop: Focus on immunization and vaccine development, exploring the mechanisms by which vaccines induce protective immunity and the scientific principles underlying vaccine design, testing, and implementation.

Objectives of the Lecture:

Historical context of early immunization methods, including smallpox variolation, and the evolution of vaccination.
Principles of protective immunization, emphasizing the need for a strong immune response that can prevent disease upon subsequent exposure to the pathogen.
Factors that make a good vaccine, such as safety, efficacy, stability, tolerability, and the potential for long-term immunity.
Types of vaccines available along with their pros and cons, including live attenuated, inactivated, subunit, and mRNA vaccines.
Examples of past successes in vaccination campaigns, highlighting the eradication of smallpox and the near-elimination of polio in many parts of the world.
Recent vaccine development advancements, such as the rapid production of COVID-19 vaccines using novel technologies like mRNA and viral vectors; discussions on the implications of these technologies for future vaccine development.

Key Terms in Immunization and Vaccination:

Immunization: Stimulating protective immunity against pathogens through various methods, crucial for public health.
Natural Immunization: Following infection and recovery from disease, the body retains a memory of the pathogen, providing immunity against future infections.
Vaccination: Intentional exposure to modified pathogens or their components to elicit an immune response without causing disease; typically involves weakened or inactivated forms of pathogens.
Vaccination rarely leads to sterilizing immunity—rather, it prepares the immune system to fight off infections more effectively should exposure occur.

Immunity Definitions:
Protection against foreign pathogens/substances (antigens), critical for a healthy immune system. The term originates from Latin "immunis," meaning exempt, signifying the body's ability to resist disease. Historical observations of immunity date back over 2000 years, with notable contributions from individuals like Thucydides, who noted that recovered individuals could nurse the ill during a plague, indicating natural immunity to the disease.

Key Historical Milestones:

430 BC: Thucydides documented immunity, setting the groundwork for future studies.
15th Century: Turks practiced variolation, a method of inducing immunity through controlled infection.
18th Century: Edward Jenner developed the cowpox vaccine that led to the eventual eradication of smallpox.
19th Century: Louis Pasteur’s research on attenuated vaccines revolutionized immunization strategies.
Over 20 Nobel Prizes awarded in immunology reflect the field's significance and extensive research contributions.

Early Smallpox Vaccination:
Variolation methods from the 15th century included inhaling smallpox crusts or inserting them into cuts, significantly influencing early vaccination strategies. Cotton Mather, a Bostonian minister, utilized variolation effectively during a smallpox outbreak in 1721, showcasing its potential benefits. Edward Jenner’s use of cowpox in 1798, demonstrating a safer alternative to variolation, laid grounds for modern vaccination practices.

Passive Immunity:
Transfer of antibodies from one individual to another, such as maternal antibodies transferred to infants through breast milk. This provides temporary protection, does not activate the recipient’s immune system, and is important against toxins (e.g., tetanus) and venoms. Passive immunity plays a critical role in protecting vulnerable populations until they can develop their own immune responses.

Era of Passive Immunotherapy:
The introduction of anti-tetanus serum during WWI significantly reduced tetanus incidence and was among the early forms of immunotherapy that utilized antibodies for treatment.

Active Immunity:
Triggers the adaptive immune response, resulting in the creation of memory cells that provide long-lasting protection. This immunity can be acquired naturally through infection or artificially through vaccination.

Immunological Memory:
A characteristic of the adaptive immune system, where a primary immune response occurs upon first exposure to an antigen, and memory cells are retained post-clearance. Upon secondary exposure to the same antigen, the body elicits a quicker and stronger immune response due to this memory.

Vaccination and Immunological Memory:
Vaccinations are designed to create specific memory cells that allow for enhanced responses to subsequent exposures, thus improving the effectiveness of the immune response.

Requirements for Effective Vaccination:
Safety, stability, cost-effectiveness, ease of administration, and provision for long-term protection are critical. Must consider socio-cultural and geographical factors for high uptake, ensuring that vaccines reach the populations that need them most effectively.

Impact of Vaccines on Poliomyelitis:
Significant advancements made in controlling polio spread worldwide through extensive immunization efforts, leading to the near eradication in several regions.

Herd Immunity:
Herd immunity occurs when a majority of individuals in a population are immune, which in turn reduces overall transmission and protects those who cannot be vaccinated.

Herd Immunity Threshold (HIT):

Poliovirus: Ro = 5-7, HIT = 80-86%.
SARS-CoV-2 (delta variant): Ro = 5-8, HIT = 80-89%.
Measles virus: Ro = 12-18, HIT = 92-94%.
Understanding these thresholds is paramount for public health strategies aimed at controlling epidemics.

Benefits of Global Immunization:
Notable control of diseases such as smallpox, polio, measles, and mumps has been achieved. However, challenges remain, such as distribution issues, high costs, lack of effective vaccines for certain diseases, and public distrust regarding vaccination.

Recommended Childhood Immunization Schedule (USA, 2022):
Vaccines include Hep B, RV, DTaP, Hib, PCV13, IPV, MMR, Varicella, HepA. Following this schedule is essential for effective disease prevention in children.

Activity Suggestion:
Draw a detailed diagram illustrating immune responses initiated by vaccination, highlighting interactions between different immune cells and the role of antibodies.

Vaccine Development History:
Historically, vaccine development has been a lengthy and costly process focused primarily on antigens. Contemporary methods encompass the use of DNA sequences and molecular interactions aimed at designing vaccines with specific objectives, improving efficiency and speed of development.

Vaccine Components:
Key components of vaccines include immunogens (the active parts that elicit an immune response), packaging materials, adjuvants that enhance the immune response, stabilizers to maintain the vaccine's effectiveness, and delivery methods that ensure optimal administration.

Delivery Methods:
Common methods include intramuscular injections, though ongoing investigations are exploring mucosal and novel routes (e.g., intranasal spray), potentially improving accessibility and ease of vaccination.

Clinical Trial Phases in Vaccine Testing (USA):
Phases include Preclinical → Phase I → Phase II → Phase III → FDA review → Post-market Phase IV. Each phase is crucial for assessing the safety and efficacy of the vaccine before public distribution.

Types of Vaccines:
Major types include whole pathogen (live/killed), subunit, particle-based, vectored vaccines, and nucleic acids, with each type exhibiting distinct mechanisms and implications for immunization strategies.

Types of Vaccines Detailed:

Live Attenuated: Weakened viruses that stimulate an immune response without resulting in disease, often providing robust immunity.
Inactivated: Contain inactivated pathogens that still elicit immune responses, e.g., poliovirus vaccine (Salk).
Virus Vector: Use harmless viruses to deliver antigens to the immune system.
Protein Subunit: Utilize purified macromolecules; examples include diphtheria and tetanus toxoids.
Vaccine-like Particles: Stabilized structures mimicking viruses to elicit immune responses.

Inactivated Vaccines Characteristics:
Can achieve immunity against multiple serotypes of a virus through chemical inactivation, often involving treatments that do not compromise antigenicity (e.g., formaldehyde). Achieving effective immunity while maintaining safety and stability is key in vaccine design.

Poliomyelitis Vaccine Impact Overview:
Documented successes in polio vaccination have resulted in dramatic decreases in incidence worldwide, emphasizing the importance of sustained vaccination efforts to maintain eradication status.

Subunit Vaccines:
These vaccines utilize purified macromolecules derived from pathogens, providing a safer alternative with fewer side effects, as seen in diphtheria and tetanus toxoids.

Role of Adjuvants:
Adjuvants enhance the immune response by various mechanisms, including releasing antigens over time and recruiting immune cells to the site of action, vital for improving vaccine efficacy.

Adjuvants Detailed:
Substances that boost the immune response without having specific antigenic properties; aluminum salts are a common example that enhances vaccine responses.

Particle or Membrane-Based Vaccines:
Utilizes structures such as virus-like particles to stabilize and deliver antigens effectively, enhancing the immunogenicity and providing a novel approach to vaccination.

Vectored Vaccines:
Employ attenuated or genetically modified pathogens as vectors for gene expression, capable of being replication-competent or defective, presenting unique advantages in immunization strategies.

Nucleic Acid Vaccines:
Utilize plasmids or mRNA to deliver genetic material that activates cellular immunity mechanisms, revolutionary due to their rapid development potential and programmability.

Pros and Cons of Vaccine Types:

Live: Robust immune responses but with risks of reversion to virulence and infection in immunocompromised individuals.
Inactivated: Generally safer; may require boosters for lasting immunity.
Subunit: Safe, reduced side effects; however, may elicit limited immune response without adjuvants.
Nucleic Acid: Provides programmable immunity; manageable cold chain requirements, but still under evaluation for long-term effects.

Vaccine Gaps:
There exists a significant lack of effective vaccines against pathogens, particularly those with complex life cycles, antigenic variation, or those that reside in privileged sites within the body (central nervous system).

Infectious Diseases without Vaccines:
Diseases such as HIV, Gonorrhea, Malaria, and Syphilis currently lack effective vaccine solutions, presenting ongoing challenges in global public health efforts.